$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Oct 16, 2025)
$292.50M
Market Cap
-
P/E Ratio
-
EPS
$63.00
52 Week High
$9.81
52 Week Low
HEALTHCARE
Sector
Field | Value |
---|---|
Ex Dividend Date | 2023-01-13 |
Declaration Date | None |
Record Date | None |
Payment Date | None |
Amount | 0.24 |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Crescent Biopharma, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to developing innovative protease therapeutics that target hemostasis and complement regulation. The company is poised to address significant unmet medical needs through its promising pipeline, which includes novel candidates designed to tackle serious conditions associated with blood coagulation and immune response. Leveraging advanced research and proprietary technologies, Crescent Biopharma aims to deliver transformative solutions within the biopharmaceutical sector, positioning itself as a key player in the evolving landscape of therapeutic advancements.